Company Research Report: Cresilon, Inc.

Company Overview

• Name: Cresilon, Inc.

• Mission: Cresilon’s mission is to save lives by providing a safe, effective, and reliable solution to stop bleeding quickly and effectively.

• Founders: Founded by Joe Landolina and Isaac Miller.

• Key People:

• Joe Landolina, CEO, Co-founder

• Isaac Miller, EVP, Co-founder

• Scott Levine, Chief Financial Officer

• Hassaan Ahmad, Vice President, Quality & Regulatory Affairs

• Irene Dris, PhD, Vice President, Technology

• Matt Lewis, Vice President, Sales

• Cidnee Vaykovich, Vice President, Business Development

• Karthik Eticala, Vice President, Manufacturing Operations

• Karina Duffy, Head of People

• Omar Ahmad, Director, Product & Portfolio Management

• Stephanie Leveen, Corporate Controller

• Headquarters: 122 18th St, Brooklyn, NY 11215, USA

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Cresilon is known for its plant-based hemostatic gels that stop bleeding in seconds, targeting veterinary and human trauma care and surgical applications.

Products

VETIGEL®

• Description: VETIGEL® is a single-use, prescription hemostatic gel specifically for veterinary use to control bleeding in animals by achieving hemostasis in seconds.

• Key Features:

• Stops bleeding on contact.

• Plant-based proprietary polymers derived from non-animal sources.

• Biocompatible, meeting ISO 10993 testing standards.

• Conforms to a wide range of wound geometries.

• Requires no manual pressure due to its mechanical seal.

• Supplied in a pre-filled ready-to-use syringe.

• FDA-cleared for veterinary use in the United States.

TRAUMAGEL®

• Description: TRAUMAGEL® is a hemostatic gel designed for temporary external use by licensed medical professionals to control moderate to severe bleeding.

• Key Features:

• FDA 510(k) cleared for temporary external use in the US.

• Creates an instant mechanical barrier against bleeding.

• Designed for use in emergency settings to improve clinical outcomes.

• Suitable for treating severe wounds, including bullet wounds and vehicular accident injuries.

Recent Developments

• New Products Launched:

• TRAUMAGEL® was recently cleared by the FDA for controlling moderate to severe external bleeding.

• New Features Added: No specific new features for existing products were specified.

• Partnerships and Collaborations:

• Cresilon has partnered with the Walter Reed Army Institute of Research to develop treatments for traumatic brain injury and has partnered with VetPlus to expand manufacturing.

• The company announced a preferred partnership with VerticalVet and an international distribution agreement with Covetrus for VETIGEL®.

• Exhibitions & Recognitions:

• Cresilon was selected to exhibit at the Vizient Innovative Technology Exchange.

• In May 2024, Cresilon was named the Most Innovative Company of the Year by Fast Company in the medical devices category.

Contact Information

• Address:

• 122 18th St, Brooklyn, NY 11215 USA

• 86 34th Street, Suite D603/D604, Brooklyn, NY 11232

• Phone: +1 (347) 435-2226

• Email: info@cresilon.com

• Website: [www.cresilon.com](http://www.cresilon.com)

Cresilon continues its journey of transforming emergency care through revolutionary hemostatic gel technology, underscoring its mission of saving lives through rapid bleeding cessation in both veterinary and human medical fields.